Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-07 06:18 am Purchase |
2021-05-24 | 13G | Galera Therapeutics, Inc. GRTX |
Orin Hirschman | 2,095,291 11.000% |
358,969 (+20.67%) |
Filing History |
| 2021-05-28 4:06 pm Sale |
2021-05-21 | 13G | Myomo, Inc. MYO |
Orin Hirschman | 279,641 4.990% |
-153,928 (-35.50%) |
Filing History |
| 2021-05-26 06:21 am Sale |
2021-05-18 | 13G | LightPath Technologies, Inc. LPTH |
Orin Hirschman | 0 0.000% |
-1,854,324 (Position Closed) |
Filing History |
| 2021-05-06 4:20 pm Purchase |
2021-04-30 | 13G | Evoke Pharma, Inc. EVOK |
Orin Hirschman | 11,814 5.300% |
1,862 (+18.71%) |
Filing History |
| 2021-04-29 6:19 pm Purchase |
2021-04-29 | 13G | Galera Therapeutics, Inc. GRTX |
Orin Hirschman | 1,736,322 11.000% |
1,736,322 (New Position) |
Filing History |
| 2021-04-16 4:07 pm Sale |
2021-04-12 | 13G | Nuvve Holding Corp. NVVE |
Orin Hirschman | 1,795 11.000% |
-2,005 (-52.77%) |
Filing History |
| 2021-04-06 06:39 am Purchase |
2021-03-19 | 13G | Nuvve Holding Corp. NVVE |
Orin Hirschman | 3,800 11.000% |
3,800 (New Position) |
Filing History |
| 2021-03-25 6:28 pm Sale |
2021-03-19 | 13G | Evoke Pharma, Inc. EVOK |
Orin Hirschman | 9,952 4.400% |
-1,853 (-15.70%) |
Filing History |
| 2021-03-17 4:10 pm Sale |
2021-03-12 | 13G | NLS Pharmaceutics AG NLSP |
Orin Hirschman | 14,430 4.900% |
-8,570 (-37.26%) |
Filing History |
| 2021-03-17 4:06 pm Sale |
2021-03-15 | 13G | Acer Therapeutics Inc. ACER |
Orin Hirschman | 0 0.000% |
-982,446 (Position Closed) |
Filing History |
| 2021-02-22 07:18 am Purchase |
2021-02-16 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Orin Hirschman | 1,611,313 11.000% |
1,611,313 (New Position) |
Filing History |
| 2021-02-11 7:15 pm Sale |
2021-01-04 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Orin Hirschman | 5,833 4.990% |
-254 (-4.17%) |
Filing History |
| 2021-02-11 6:25 pm Sale |
2021-02-09 | 13G | Cyclo Therapeutics, Inc. CYTH |
Orin Hirschman | 209,383 4.990% |
-208,617 (-49.91%) |
Filing History |
| 2021-02-10 4:26 pm Purchase |
2020-12-31 | 13G | NanoVibronix, Inc. NAOV |
Orin Hirschman | 38,573 3.900% |
17,090 (+79.55%) |
Filing History |
| 2021-02-10 4:23 pm Purchase |
2020-12-31 | 13G | Myomo, Inc. MYO |
Orin Hirschman | 433,569 9.500% |
17,510 (+4.21%) |
Filing History |
| 2021-02-10 4:21 pm Purchase |
2020-12-31 | 13G | LightPath Technologies, Inc. LPTH |
Orin Hirschman | 1,854,324 7.100% |
20,193 (+1.10%) |
Filing History |
| 2021-02-10 4:18 pm Purchase |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Orin Hirschman | 501,025 11.000% |
28,000 (+5.92%) |
Filing History |
| 2021-02-10 4:13 pm Purchase |
2020-12-31 | 13G | Acer Therapeutics Inc. ACER |
Orin Hirschman | 982,446 11.000% |
982,446 (New Position) |
Filing History |
| 2021-02-10 2:36 pm Purchase |
2020-12-31 | 13G | EMCORE Corporation EMKR |
Orin Hirschman | 231,036 7.800% |
33,135 (+16.74%) |
Filing History |
| 2021-02-09 5:06 pm Sale |
2021-02-09 | 13G | Energy Focus, Inc. EFOI |
Orin Hirschman | 0 0.000% |
-42,857 (Position Closed) |
Filing History |